Manchester, UK - 25 October 2018 - SkinBioTherapeutics plc (AIM: SBTX - "SkinBioTherapeutics" or the "Company") a life sciences company focused on skin health, has announced its full year results for the year to 30 June 2018....
25th October, 2018 Read MoreCEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening https://www.sharesmagazine.co.uk/video/dr-catherine-oneill-ceo-skinbiotherapeutics-sbtx-2...
17th October, 2018 Read MoreManchester, UK - 19 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the 'Company'), a life science company focused on skin health, confirms that it has commenced its human study being carried out on its SkinBiotix® technology....
19th September, 2018 Read MoreCEO, Prof. Cath O'Neill presenting at the AJ Bell Investor Evening...
14th September, 2018 Read MoreSkinBioTherapeutics will be attending and presenting at the Shares and AJ Bell evening event in Manchester on October 10 2018 at the Macdonald Manchester Hotel (nr Piccadilly Station). Shareholders and potential investors can register now for free at: https://www.sharesmagazine.co.uk/events...
14th September, 2018 Read MoreManchester, UK - 03 September 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, is pleased to provide an update to its announcement of 16 August 2018. The stability criteria required for its human study has been met and the Company e...
3rd September, 2018 Read More